Tirzepatide Weight Loss in Miami

Searching for Tirzepatide weight loss in Miami? Aurelia Med Spa's North Miami clinic runs fully physician-supervised Tirzepatide programs — the dual GIP/GLP-1 medication that has produced the strongest average weight loss of any drug studied to date. This isn't a mail-order pen: every program includes comprehensive labs, a medical consultation, supervised dose titration, weekly check-ins, and body-composition tracking.

Tirzepatide works by activating two gut-hormone pathways at once, which amplifies appetite suppression and metabolic benefit beyond single-pathway GLP-1s. Programs start at $1,299, and if you're weighing your options our Semaglutide vs Tirzepatide comparison breaks down the differences. Tirzepatide is one track within our broader medical weight loss in Miami program — we confirm the right fit for you at your consultation.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two gut-hormone pathways rather than one, which is why it has posted the strongest average weight loss of any medication to date (around 20%+ at the highest doses in trials). It quiets appetite, slows gastric emptying, and improves how your body handles blood sugar. It isn't right for everyone, and it should always be titrated under medical supervision. For an authoritative, unbiased overview of prescription weight-management medications, the National Institute of Diabetes and Digestive and Kidney Diseases is an excellent resource — and we walk you through it at your consultation.

The clinics losing patients are the ones that hand out a pen and disappear. Aurelia does the opposite: our Tirzepatide programs pair the medication with lab work, weekly medical check-ins, nutrition coaching, and body-composition tracking so you lose fat (not muscle) and keep it off. Many patients add IV therapy in North Miami for energy through the titration phase, and we address any post-weight-loss facial volume loss with dermal filler. Larger programs can be split with Cherry or Care Credit financing.

You don't start at a full dose. Tirzepatide begins low and is increased gradually, because slow titration is the single most important factor in tolerating it well. Most patients notice appetite changes within the first week or two. The most common side effects are gastrointestinal, such as mild nausea, reduced appetite or occasional constipation, and they tend to cluster in the early weeks and around each dose increase.

That's what weekly check-ins are for: our medical team adjusts the pace to how you feel rather than asking you to push through. Visible loss then builds steadily over the following months. Our guide to what to expect from medical weight loss in Florida walks through every stage.

Candidacy is a medical decision made after your consultation and baseline labs (A1c, metabolic panel and thyroid). Our programs are designed for first-time medical weight-loss patients who want a fully supervised start, people who've plateaued on previous attempts, and patients whose weight is tied to metabolic or hormonal change, such as insulin resistance, perimenopause or menopause. If you're new to GLP-1s, the 2-month starter is built for exactly that and ends with a clear decision point: continue, step up, or move to maintenance. Tirzepatide isn't right for everyone, and if it isn't right for you, we'll tell you plainly.

The goal is to lose fat, not muscle. That means adequate protein, resistance training and tracking body composition with a Styku 3D body scan rather than just watching the scale; steady loss protects muscle better than rapid loss. The scan measures lean mass, body-fat percentage and visceral fat, and we rescan every 4–8 weeks during an active program, so you'll know you're losing the right kind of weight. Some patients from Aventura and Brickell add EmSculpt to rebuild tone in the abdomen or glutes. If you notice facial hollowing after significant loss, our Ozempic face guide explains how it's addressed.